Precision Biosciences (DTIL) Sales of Property, Plant and Equipment (2023 - 2026)

Precision Biosciences (DTIL) Sales of Property, Plant and Equipment (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 27,000.00
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Precision Biosciences 178.85 Mn 150.56 Mn - 4,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 4,000.00
Mar 31, 2026 4,000.00
Dec 31, 2025 44,000.00
Dec 31, 2025 44,000.00
Sep 30, 2025 17,000.00
Sep 30, 2025 17,000.00
Jun 30, 2025 5,000.00
Jun 30, 2025 5,000.00
Mar 31, 2024 60,000.00
Mar 31, 2024 60,000.00
Dec 31, 2023 37,000.00
Dec 31, 2023 37,000.00